Showing results (1051-1060 of 1,171) with videos related to
Sort By:
Pageof 118
Journal of Cancer Research and Clinical Oncology|June 16, 2010
Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resectionDan-Dan Wang, Yi-Ming Zhao, Lu Wang, et al.Cancer Letters|June 6, 2026
Multi-Omic Profiling Identifies TREM2+ Lipid-laden Macrophages as Inflammatory Drivers and Therapeutic Targets of Colorectal Cancer Liver MetastasisPeng-Xiang Wang, Yu-Chen Zhong, Wen-Jing Zheng, et al.Journal of Cancer Research and Clinical Oncology|May 13, 2008
Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentialsGuo-Ming Shi, Yang Xu, Jia Fan, et al.Veterinary Parasitology|March 23, 2010
The preparation of neem oil microemulsion (Azadirachta indica) and the comparison of acaricidal time between neem oil microemulsion and other formulations in vitroJiao Xu, Qiao-Jia Fan, Zhong-Qiong Yin, et al.The Journal of Clinical Investigation|June 19, 2019
Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cellsYoshiyuki Mishima, Akihiko Oka, Bo Liu, et al.Molecular Oncology|September 20, 2021
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective studyGui-Qi Zhu, Wei-Ren Liu, Zheng Tang, et al.Cell Death & Disease|February 2, 2023
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axisXiao-Jun Guo, Xiao-Yong Huang, Xuan Yang, et al.Cell Reports|February 29, 2024
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapyZhong-Chen Li, Jie Wang, He-Bin Liu, et al.Clinical and Translational Medicine|May 14, 2024
Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort studyDe-Zhen Guo, Ao Huang, Ying-Chao Wang, et al.Journal of Hepatology|February 14, 2022
PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapyMincheng Yu, Zheng Chen, Qiang Zhou, et al.Pageof 118